MATT SHIELDS
LOGISTICS
MATT SHIELDS
TITLE: EXECUTIVE VICE PRESIDENT GLOBAL OPERATIONS
COMPANY: TEVA PHARMACEUTICALS
INDUSTRY: PHARMACEUTICALS
Matt oversees 33 sites across 25 countries, driving a strategic transformation to modernise Teva’ s supply network, ensuring millions of patients receive reliable medicines while supporting the company’ s Pivot to Growth strategy.
Alongside this, a cloud-based analytics platform consolidates KPIs and trend data into a centralised environment, while a control-tower model integrates logistics data across regions and transport modes.
Matt adds:“ The logistics models that win will be those designed for resilience, speed and intelligence, because that’ s what it takes to keep medicines moving to the patients who depend on them.”
Teva is also transitioning from multiple legacy ERP systems to a single global platform – a move Matt describes as essential for sharpening visibility and standardising decision-making at scale. Through Teva Rise, the company’ s openinnovation programme launched in 2025, the company is partnering with startups to co-develop solutions at pace.
“ AI is already unlocking new possibilities for us in logistics – scanning high volumes of unstructured data to identify patterns, bottlenecks and reducing cycle times with dispatchreadiness predictions and intelligent route optimisation.”
Data-driven, human-led resilience One of the persistent tensions in any global standardisation effort is how to accommodate local regulatory and operational realities without undermining the coherence of the whole.
Sangam has a clear framework for navigating it:“ The balance comes from separating what must be unified from what must remain flexible. Planning logic, data definitions and workflow structure should be consistent across
supplychaindigital. com
89